You have 9 free searches left this month | for more free features.

City

Bethesda (1)

Brick (1)

Canton (1)

Suzhou (1)

Tianjin (1)

Condition

Acute Myeloid Leukemia (1)

Lung Adenocarcinoma (1)

MDS (1)

Osteosarcoma (1)

Solid Tumors (1)

Overall Status

Suspended (1)

Terminated (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Innovent Biologics (Suzhou) Co. Ltd. (3)

Collaborator

Intervention

ibi188 (3)

azacitidine (2)

bevacizumab (1)

cisplatin/carboplatin (1)

gm-csf (1)

pemetrexed (1)

sintilimab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

ibi188

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Solid Tumors, Lung Adenocarcinoma, Osteosarcoma Trial in Tianjin (IBI188, GM-CSF, Cisplatin/Carboplatin)

Terminated

Solid Tumors
+2 more

IBI188
+5 more

Tianjin, China

Tianjin Medical University Cancer Institute and Hospital

Oct 3, 2022

MDS Trial in Bethesda, Brick, Canton (IBI188, Azacitidine)

Suspended

MDS

IBI188
Azacitidine

Bethesda, Maryland
+2 more

Dec 17, 2020

Acute Myeloid Leukemia Trial in Suzhou (IBI188, Azacitidine)

Unknown status

Acute Myeloid Leukemia

IBI188
Azacitidine

Suzhou, Jiangsu, China

The First Affiliated Hospital of Soochow University

Oct 19, 2020